Both in Biotechnology
Fate Therapeutics vs X4 Pharmaceuticals
Over the past year FATE returned +138.0% and XFOR returned −13.4%; their daily moves had a correlation of 0.22.
FATE +138.0% XFOR −13.4%Growth of $1, one year, split-adjusted
| Metric | FATE | XFOR |
|---|---|---|
| Price | $2.38 | $2.90 |
| Market cap | $285.2M | $287.5M |
| Today | 0.00% | −3.81% |
| 1 month | −2.1% | −28.2% |
| 6 months | +110.6% | −27.3% |
| Year to date | +142.2% | −27.5% |
| 1 year | +138.0% | −16.2% |
| Revenue growth (YoY) | +9.2% | +346.3% |
| Gross margin | 100.0% | 81.6% |
| Net margin | −1448.6% | −183.5% |
| P/E (TTM) | — | — |
| Price / sales | 43.9× | 18.1× |
| Net cash | $153.8M | $131.2M |
| Dividend yield | — | — |
| Volatility (60d) | 59.6% | 64.2% |
| Short % of float | 9.2% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).